fda glp-1 enforcement news Compounding Crackdown FDA is moving to restrict

[DOI] [PMC free article] [PubMed] [Google Scholar] 105.J.R

This metabolic adaptation is one of the most frustrating experiences for people who feel they are doing everything right

He called the drugs game changers, adding that he has seen patients lose 50 pounds or more within a few months of starting the drugs and no longer need medications for diabetes or other conditions

That began to change with a pilot the Centers for Medicare & Medicaid Services announced on May 6, 2026 and launched on July 1, offering certain Part D beneficiaries GLP-1 prescriptions for a flat $50 monthly copay, according to NPRs coverage of the rollout

And this one honestly made me stop and reread the literature because it is, um, frankly, life changing if it, if it works for all endo patients now

doi:10.1016/j.bbr.2018.08.006 196